PSK-3668

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePSK-3668
Drug Alias Namepure anti-estrogen (ProStrakan)pure anti-estrogen (ProSkelia)PSK-3668
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha degraders
TargetsEstrogen receptor alpha
Therapy Area/IndicationsBreast NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProSkelia Pharmaceuticals SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A